Abstract:Abstract Background Over 90% of children with reported penicillin allergy can tolerate penicillin without incident. Developing effective and safe strategies to remove inappropriate penicillin allergies has the potential to improve care; however, guidance on how to identify, test, and delabel patients is limited. Methods In April 2019, Children’s Hospital Colorado (CHCO) implemented a penicillin allergy clinical pathway (CP) alongside a risk assessment tool to stratify patients based on allergic history (Figure 1). Patients at “no increased risk” were educated and delabeled without testing. Low risk patients were offered an oral amoxicillin drug challenge with close observation. A single, non-graded, treatment dose of amoxicillin (45 mg/kg, max dose 1000mg) was used for low risk patients, and no preceding allergic skin testing was performed. Patients with no signs or symptoms of allergic response 60 minutes after amoxicillin administration were delabeled. Children delabeled of penicillin allergies on the CHCO hospital medicine service were compared between the pre-CP (1/1/17-3/31/19) and post-CP (4/1/19-3/31/20) cohorts. Figure 1. Penicillin Allergy Risk Assessment Results Pre-CP, 683/10624 (6.4%) patients reported a penicillin allergy and 18/683 (2.6%) were delabeled by discharge. Post-CP, 345/6559 (5.3%) patients reported a penicillin allergy and 47/345 (13.6%) were delabeled by discharge (P-value < 0.0001, Figure 2). Among the 47 post-CP patients, 11 were delabeled by history alone, 19 underwent oral amoxicillin drug challenge per CP, and 17 received a different treatment dose penicillin per treatment team. Only one penicillin-exposed patients had a reaction. This patient developed a delayed, non-progressive rash and had penicillin allergy restored to their chart. No patient required emergency medical intervention, and none were “relabeled” penicillin allergic in the 6 months following discharge. Figure 2. Monthly Rate of Penicillin Allergic Patients Delabeled by Discharge Conclusion A drug challenge using a single non-graded dose of oral amoxicillin is a safe and effective strategy to delabel low risk children of inappropriate penicillin allergies when implemented alongside a risk assessment tool. Further studies are needed to evaluate the long-term benefits of delabeling inappropriate penicillin allergies and to continue monitoring for adverse events. Disclosures All Authors: No reported disclosures

Adult penicillin allergy programmes in Australian hospitals: a practical guide from the National Antibiotic Allergy Network

The challenge of de‐labeling penicillin allergy

Introduction of a penicillin allergy de-labelling program with direct oral challenge and its effects on utilization of beta-lactam antimicrobials: a multicenter retrospective parallel cohort study

Promoting penicillin allergy de‐labeling for children attending a hematology clinic

Penicillin Allergy Testing and Delabeling for Patients Who Are Prescribed Penicillin: A Systematic Review for a World Health Organization Guideline

Proactive management of penicillin and other antibiotic allergies

Effectiveness, barriers and facilitating factors of strategies for active delabelling of patients with penicillin allergy labels: a systematic review protocol

The appropriateness of penicillin allergy de-labelling by non-allergist clinical ward teams

Rising to the Challenge: An ID Provider–Led Initiative to Address Penicillin Allergy Labels at a Large Veterans Affairs Medical Center

Patient Perceptions of Penicillin Allergy Testing in a Public Health System

Retrospective study on penicillin allergy delabeling and evaluation of an antibiotic allergy assessment tool

Comparative Performance of 4 Penicillin-Allergy Prediction Strategies in a Large Cohort

Factors influencing implementation and adoption of direct oral penicillin challenge for allergy delabelling: a qualitative evaluation

Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge

A Multicentre Observational Study to Investigate Feasibility of a Direct Oral Penicillin Challenge in De-labelling 'Low Risk' Patients with Penicillin Allergy by Non-Allergy Healthcare Professionals (SPACE study) - implications for healthcare systems

Antepartum vs postpartum amoxicillin oral challenge in pregnant patients with a reported penicillin allergy: A two-center prospective cohort study

Safe Penicillin Allergy Delabeling in Primary Care: A Systematic Review and Meta-Analysis

Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy

Resource utilization and cost assessment of a proactive penicillin allergy de-labeling program for low-risk inpatients

[Reevaluation of penicillin allergy labeling, appropriate use of β-lactam antibiotics, and multidrug resistance]

1332. Single Dose Oral Amoxicillin Challenge is a Safe and Effective Strategy to Delabel Penicillin Allergies among Low Risk Hospitalized Children